Molecular Designs Acquires Lamda Biotech
September 25, 2024
Molecular Designs, a Birmingham-based provider of PCR assays and related reagents and equipment, has acquired Lamda Biotech, a St. Louis provider of molecular biology research products and kits. The deal will expand Molecular Designs’ product portfolio and manufacturing capacity while broadening access to academic research and pharmaceutical customers and strengthening R&D and technical talent.
- Buyers
- Molecular Designs
- Targets
- Lamda Biotech
- Industry
- Biotechnology
- Location
- Missouri, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.